All sites C00-96,D32-33,D42-43,D45-47,D76 297 85.5 5.0 4.4 2.1 3.0
Mouth, pharynx C00-14 5 96.3 3.7 - - -
  Lip C00 1 100.0 - - - -
  Tongue C02 1 100.0 - - - -
  Mouth, other C03-06 2 100.0 - - - -
  Salivary glands C07-08 1 66.7 33.3 - - -
  Pharynx C01,C09-14 1 100.0 - - - -
Digestive organs C15-26 61 80.6 5.9 5.9 3.9 3.6
  Oesophagus C15 2 100.0 - - - -
  Stomach C16 6 96.4 - - 3.6 -
  Small intestine C17 1 80.0 - - 20.0 -
  Colon C18 19 96.8 - - 1.1 2.1
  Rectum, rectosigmoid C19-20 10 100.0 - - - -
  Anus C21 1 100.0 - - - -
  Liver C22 5 58.3 12.5 20.8 4.2 4.2
  Gallbladder, bile ducts C23-24 4 63.2 15.8 - 10.5 10.5
  Pancreas C25 13 50.8 19.0 19.0 7.9 3.2
  Other digestive organs C26 2 25.0 - 12.5 12.5 50.0
Respiratory organs C30-39 24 48.4 23.8 16.4 5.7 5.7
  Nose, sinuses C30-31 1 100.0 - - - -
  Larynx, epiglottis C32 - - - - - -
  Lung, trachea C33-34 24 46.6 24.6 16.9 5.9 5.9
  Mediastinum, pleura C38 0 100.0 - - - -
Bone C40-41 0 100.0 - - - -
Melanoma of the skin C43 6 100.0 - - - -
Skin, non-melanoma C44 11 100.0 - - - -
Mesothelioma C45 1 85.7 14.3 - - -
Autonomic nervous system C47 - - - - - -
Soft tissues C48-49 3 100.0 - - - -
Breast C50 88 98.6 0.5 - 0.2 0.7
Female genital organs C51-58 31 93.6 1.3 2.6 1.9 0.6
  Cervix uteri C53 3 92.9 - 7.1 - -
  Corpus uteri C54 15 97.4 - - 2.6 -
  Uterus, other C55,C58 0 50.0 - - - 50.0
  Ovary C56 9 89.4 4.3 6.4 - -
  Other female genital C51-52,C57 3 93.8 - - 6.3 -
Urinary organs C64-68 10 94.2 3.8 1.9 - -
  Kidney C64 6 93.8 3.1 3.1 - -
  Bladder and urinary tract2 C65-68 4 95.0 5.0 - - -
Eye C69 - - - - - -
Brain, central nervous system C70-72,D32-33,D42-43 13 71.9 - 14.1 3.1 10.9
Thyroid gland C73 8 92.9 7.1 - - -
Other endocrine glands C74-75 0 100.0 - - - -
Illdefined or unknown C76,C80 8 40.0 12.5 25.0 10.0 12.5
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 27 79.9 9.0 2.2 1.5 7.5
  Hodgkin lymphoma C81 0 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 13 100.0 - - - -
  Malignant immunoproliferative diseases C88 0 - - 100.0 - -
  Myeloma and other plasma cell tumors C90 6 60.7 17.9 3.6 3.6 14.3
  Leukaemia C91-95 5 62.5 29.2 4.2 - 4.2
  Myelodysplastic syndromes D46 1 40.0 - - 20.0 40.0
  Myeloproliferaitive neoplasms D45,D47 1 57.1 - - - 42.9
Not included above
  Carcinoma in situ of the breast D05 16 100.0 - - - -
  Cervix uteri, non-invasive neoplasms 15 100.0 - - - -
  Borderline tumour of the ovary D39 3 100.0 - - - -
  Basal cell carcinoma of the skin 65 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.